KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) Non Operating Income (2016 - 2025)

Cme (CME) has disclosed Non Operating Income for 17 consecutive years, with -$1.3 billion as the latest value for Q4 2025.

  • On a quarterly basis, Non Operating Income rose 69.36% to -$1.3 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$4.8 billion, a 1.17% decrease, with the full-year FY2025 number at -$4.8 billion, down 32.1% from a year prior.
  • Non Operating Income was -$1.3 billion for Q4 2025 at Cme, up from -$3.9 billion in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $1.3 billion in Q4 2022 to a low of -$4.1 billion in Q4 2024.
  • A 5-year average of -$655.2 million and a median of -$21.7 million in 2021 define the central range for Non Operating Income.
  • Peak YoY movement for Non Operating Income: soared 2611.3% in 2021, then crashed 2660.05% in 2025.
  • Cme's Non Operating Income stood at $460.0 million in 2021, then surged by 186.85% to $1.3 billion in 2022, then crashed by 278.64% to -$2.4 billion in 2023, then plummeted by 74.77% to -$4.1 billion in 2024, then surged by 69.36% to -$1.3 billion in 2025.
  • Per Business Quant, the three most recent readings for CME's Non Operating Income are -$1.3 billion (Q4 2025), -$3.9 billion (Q3 2025), and $201.0 million (Q2 2025).